by Elena Iemma | May 13, 2021 | Featured, News
PROVIDENCE, RI, May 13, 2021 /PRNewswire/ — EpiVax Therapeutics, Inc. (“EVT”) announces the publication “Multi‑step screening of neoantigens’ HLA and TCR‑interfaces improves prediction of survival” in Scientific Reports. This study demonstrates a superior method...
by Elena Iemma | Mar 11, 2021 | Events, Featured, Webinars
Aimee Mattei, Senior Project Manager on our Bioinformatics team, will be presenting to the AAPS BPABC(biopharmaceutical product attributes and biological consequences) Community on March 18th at 12pm ET. You’ll need to join the group to register, membership is...
by Elena Iemma | Feb 18, 2021 | Featured, Thinking Out Loud -Blog
Zoom Fatigue is REAL! Like you, we’ve been insanely busy with virtual conferences in the last few weeks. We are all REALLY looking forward to meeting in person again. Meanwhile, my Zoom-buddy Jack has become quite the lap(top)-dog! The good news is that...
by Elena Iemma | Feb 17, 2021 | Featured, News
PROVIDENCE, RI, February 17, 2021 /PRNewswire/ — EpiVax, Inc. (“EpiVax”) today announces its participation in the INDIGO consortium – a partnership of public and private research and development organizations from the EU, India, and United States (funded by the...
by Elena Iemma | Feb 17, 2021 | Events, Featured, Webinars
EpiVax CEO/CSO Annie De Groot hosted a talk for the FDA Office of Tissues and Advanced Therapies (OTAT) group on February 11, 2021. Annie presented the latest on EpiVax’s iVAX Toolkit in her talk “Epitope Selection for Cancer Vaccines”. JanusMatrix,...